Literature DB >> 11526502

Functional cooperation between JunD and NF-kappaB in rat hepatocytes.

M Rahmani1, P Péron, J Weitzman, L Bakiri, B Lardeux, D Bernuau.   

Abstract

AP-1 and NF-kappaB are rapidly activated during liver regeneration. Whether these parallel inductions have potential functional implications is not known. Isolated rat hepatocytes were stimulated with two mitogens, epidermal growth factor or hepatocyte growth factor and with tumor necrosis factor alpha, a cytokine involved in the liver regenerative response in vivo and a strong inducer of NF-kappaB. All three cytokines increased AP-1 and NF-kappaB binding to their cognate cis-element and induced a 2.5-fold activation of NF-kappaB-dependent transcription. Inactivation of AP-1 by TAM67, a dominant negative mutant of AP-1 drastically inhibited basal and cytokine-induced NF-kappaB transactivation. Overexpression of Jun D, but not of the other Jun or Fos proteins increased by threefold NF-kappaB transactivation. Functional cooperation between JunD and p65 was demonstrated in a simple Gal-hybrid system. Finally, a twofold decrease in NF-kappaB transactivation was found in hepatocytes isolated from JunD(-/-) mice compared with hepatocytes from JunD(+/+) mice. Altogether these data demonstrate a functional cooperation of p65 with JunD, a major constituent of AP-1 in normal hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526502     DOI: 10.1038/sj.onc.1204678

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  PI3K limits TNF-alpha production in CD16-activated monocytes.

Authors:  Phillip R Kramer; Vanessa Winger; Jayne Reuben
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

2.  Pooled ChIP-Seq Links Variation in Transcription Factor Binding to Complex Disease Risk.

Authors:  Ashley K Tehranchi; Marsha Myrthil; Trevor Martin; Brian L Hie; David Golan; Hunter B Fraser
Journal:  Cell       Date:  2016-04-14       Impact factor: 41.582

3.  Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.

Authors:  Kris A Steinbrecher; Willie Wilson; Patricia C Cogswell; Albert S Baldwin
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

4.  Activator protein-1 activation in acute lung injury.

Authors:  Ren-Feng Guo; Alex B Lentsch; J Vidya Sarma; Lei Sun; Niels C Riedemann; Shannon D McClintock; Stephanie R McGuire; Nico Van Rooijen; Peter A Ward
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

5.  Gene expression profile analysis of the spontaneous reversal of rat hepatic fibrosis by cDNA microarray.

Authors:  Qin Pan; Zhong-Bing Zhang; Xin Zhang; Jian Shi; Yue-Xiang Chen; Ze-Guang Han; Wei-Fen Xie
Journal:  Dig Dis Sci       Date:  2007-03-16       Impact factor: 3.199

6.  Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity.

Authors:  Anindita Bhoumik; Nic Jones; Ze'ev Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

Review 7.  Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis.

Authors:  S J Cooper; G T Bowden
Journal:  Curr Cancer Drug Targets       Date:  2007-06       Impact factor: 3.428

8.  Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.

Authors:  William G Dilley; Somasundaram Kalyanaraman; Sulekha Verma; J Perren Cobb; Jason M Laramie; Terry C Lairmore
Journal:  Mol Cancer       Date:  2005-02-03       Impact factor: 27.401

9.  An initial phase of JNK activation inhibits cell death early in the endoplasmic reticulum stress response.

Authors:  Max Brown; Natalie Strudwick; Monika Suwara; Louise K Sutcliffe; Adina D Mihai; Ahmed A Ali; Jamie N Watson; Martin Schröder
Journal:  J Cell Sci       Date:  2016-04-27       Impact factor: 5.285

10.  Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma.

Authors:  Sun Yang; Frank L Meyskens
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.